NYSE : CCM
Concord Medical Services Holdings Limited — Key statistics
Healthcare · Medical Care Facilities · China
Last price 3.66 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 15.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 15.50M |
| Enterprise Value | 492.63M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 4.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 18.02% |
| Owned by Institutions (%) | 0.51% |
| Float | 1.38M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.24 |
| Forward PS | n/a |
| PB Ratio | 0.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 7.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.48 |
| Quick Ratio | 0.18 |
| Debt / Equity | 1.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.57 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -21.88% |
| Return on Assets (ROA) | -2.25% |
| Return on Invested Capital (ROIC) | -4.61% |
| Return on Capital Employed (ROCE) | -5.21% |
| Weighted Average Cost of Capital (WACC) | 3.21% |
| Revenue Per Employee | $107,935 |
| Profits Per Employee | -$21,753 |
| Employee Count | 610 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 10.95 |
Taxes
| Measure | Value |
|---|
| Income Tax | 866,979 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.82 |
| 52-Week Price Change | -32.64% |
| 50-Day Moving Average | 3.91 |
| 200-Day Moving Average | 4.26 |
| Relative Strength Index (RSI) | 47.58 |
| Average Volume (20 Days) | 16,129 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 6,821 |
| Short Previous Month | 13,607 |
| Short % of Shares Out | 0.49% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.63 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 65.84M |
| Gross Profit | 3.69M |
| Operating Income | -34.22M |
| Pretax Income | -53.38M |
| Net Income | -13.27M |
| EBITDA | -14.25M |
| EBIT | -34.22M |
| Loss Per Share | -$3.04 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 42.58M |
| Total Debt | 519.70M |
| Net Cash | -477.13M |
| Net Cash Per Share | -$109.89 |
| Equity (Book Value) | 264.51M |
| Book Value Per Share | -69.25 |
| Working Capital | -144.76M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -30.30M |
| Capital Expenditures | -13.71M |
| Depreciation & Amortization | 20.97M |
| Net Borrowing | -55.25M |
| Free Cash Flow | -44.01M |
| FCF Per Share | -$10.14 |
Margins
| Measure | Value |
|---|
| Gross Margin | 5.61% |
| Operating Margin | -51.97% |
| Pretax Margin | -81.07% |
| Profit Margin | -20.15% |
| EBITDA Margin | -21.65% |
| EBIT Margin | -51.97% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -85.08% |
| FCF Yield | -283.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.17 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |